enbendazole is a broad spectrum benzimidazole vermifuge traditionally used in the veterinary market to kill gastrointestinal parasites including: giardia, hookworms, roundworms, whipworms, the tapeworm genus Taenia (but not effective against Dipylidium caninum, a common dog tapeworm), aelurostrongylus, paragonimiasis, pinworms, strongyles, and strongyloides that can be administered to sheep, cattle, horses, fish, dogs, cats, rabbits, and seals. Fenbendazole is very closely related to Mebendazole, which is approved as an intestinal anthelminthic for human use worldwide, and is even on WHO's Model List of Essential Drugs.

Renewed interest in fenbendazole outside its traditional, on label use, has been generated as a result of the publicity of surrounding the case of Joe Tippens, a man from Edmond, Oklahoma, who cured his advanced Stage IV small cell lung cancer. Tippens cancer was reportedly so bad -- with mets to the neck, pancreas, bone, liver, bladder, and lymph -- that he was told to "go home and arrange for hospice care." Tippens tells his story in a BitChute video post, Joe Tippens cures terminal cancer with pet medicine.

Since his miraculous cure, Joe has incorporated his own experience into a protocol that incorporates curcumin and CBD oil. (Our opinion is that on account of its anti-inflammatory action, the curcumin, the primary constituent of turmeric, makes the greater anti-cancer contribution in this regimen).

An Arizona State University student translated Joe Tippens blog into "two different Chinese languages" (mandarine and cantonese), posted the text in China, and it has not been read by millions of Chinese readers. (Go to 17:25). The success of the phenomenon is such that the editor of the largest newsletter in Shanghai told Tippens "you're a rock star in China." Whether this is an exaggeration or not is quite beside the point. Our interest began when we began getting an inordinate number of anecdotal reports that people were benefiting from the use of fenbendazole, and although not even sees their cancer eliminated -- (and, in fact, there are clearly instances, such as hormone-driven breast cancers, where the use of fenbendazole may be contraindicated) -- few report that they did not experience benefit.
Korean radiology oncologist, Kim Ja-Young, has stated publicly that "fenbendazole has been safe for 40 years, and the absorption rate of human drugs is very low at 20%, making it difficult to display toxicity. In addition, this substance is poisonous to low-level organisms, such as parasites, and less toxic to high-level organisms such as humans and mammals."

Joe Tippens has reported that he never experienced any side effects from taking fenbendazole, but others have, including "mild diarrhea and mild stomach discomfort." I personally have known a couple cases of people who took fenbendazole to successfully treat SIBO (small intestinal bacterial overgrowth) and experienced no side effects -- (at dosages in the 800 to 1,000 mg. per day dosage range, the rough equivalent of one of our capsules, 1x day.)
The European Medicines Agency reported in 2014 that "Fenbendazole seems to be well tolerated in humans after oral exposure (single oral dose up to 2,000 mg/per person; 500 mg/per person for 10 consecutive days)".

Tippens initially grabbed attention by saying that he cured his cancer with an $8 "dog dewormer." As in everything else, the devil is in the details. Panacur C, which is now widely being used for this purpose, is a box of three one-gram packages. Each one contains 222 mg. of fenbendazole. So the $8.20 box you see in the previous link is actually for 666 mg. This equates to about $12.30 per gram. By way of comparison, our Fenbendazole is 99% pure and contains close to 60 grams, and at $39.95, equates to $ 0.67 per gram, or a tiny fraction of Panacur's price. Bulk prices are available, but even these are 50% more expensive than our prices.
Our view is that Tippens recommended 222 mg. per day dosage is too light. Studies have been done with humans taking as much as 2-3 grams per day without ill-effect. We feel that one capsules (800 mg.) is much closer to the ideal daily dosage, with tougher cases taking two capsules per day.
Other Advisements and Precautions: As in the case of Lufenuron dosing, we strongly recommend that you take our Fenbendazole capsules with one to two teaspoons (5 to 10 mg.) of edible fat -- preferably saturated fat, like coconut oil. Avocado oil is another good choice, and lastly olive oil. This helps metabolize the product.
Avoid table sugar, commercial fructose, and other artificial sweeteners while on this protocol. Avoid taking this product if you are pregnant or lactating. Keep out of reach of children, and always store in a cool dry place. The product begins to degenerate at 86 degrees F.
A daily intake of one gram of turmeric per day concurrent with usage is beneficial and a valuable adjunct.

Why We Decided to Make
This Product Available

Insert here.

Patents, Studies, Rebuttals,
Comments Concerning Fenbendazole

A Drug Made for Animals and Taken by Humans to Treat Cancer: Fenbendazole -- Exhaustive research data on the use of fenbendazole in cancer treatment. Put out by Cancer Treatments -- from Research to Application, Cancer Treatment Research.
Fenbendazole acts as a moderate microtubule destabilizing agent and causes cancer cell death by modulating multiple cellular pathways (Aug., 2018) -- Drugs that are already clinically approved or experimentally tested for conditions other than cancer, but are found to possess previously unrecognized cytotoxicity towards malignant cells, may serve as fitting anti-cancer candidates. Methyl N-(6-phenylsulfanyl-1H benzimidazol-2-yl) carbamate [Fenbendazole, FZ], a benzimidazole compound, is a safe and inexpensive anthelmintic drug possessing an efficient anti-proliferative activity.
Unexpected antitumorigenic effect of fenbendazole when combined with supplementary vitamins (Nov., 2008) -- Found that fenbendazole exhibited antitumor effects in mice when supplemental vitamins were included.
Impairment of the Ubiquitin-Proteasome Pathway by Methyl N-(6-Phenylsulfanyl-1H-benzimidazol-2-yl ) carbamate Leads to a Potent Cytotoxic Effect in Tumor Cells / A Novel Antiproliferative Agent with a potential therapeutic implication (Jun., 2012) -- "Fenbendazole (FZ) (methyl N-(6-phenylsulfanyl-1H-benzimidazol-2-yl)carbamate) exhibits a potent growth-inhibitory activity against cancer cell lines but not normal cells.

• Fenbendazole inhibits the cellular proteasome function dose and time-dependently and leads to accumulation of ubiquitylated derivatives of various cellular proteins, including p53, which, in turn, leads to apoptosis via the mitochondrial pathway
• The cells first undergo G2/M arrest followed by apoptosis.
• Fenbendazole induced endoplasmic reticulum stress, reactive oxygen species production, decreased mitochondrial membrane potential, and cytochrome c release that eventually led to cancer cell death.
  

Drug library screen reveals benzimidazole derivatives as selective cytotoxic agents for KRAS-mutant lung cancer (Jun., 2019) -- Joe Tippins has indicated that in addition to the cure of his own small cell lung cancer, he knows many others who have, likewise, seen their lung cancers go into remission.
Benzimidazole [class of compounds that include Fenbendazole] as Novel Therapy for Hormone-Refractory Metastatic Prostate Cancer (May, 2011) -- Conclusion: "Benzimidazoles were identified from a screen that selectively target highly metastatic prostate cancer cells but not toxic to normal cells. We determined that the preferential antitumor activity of these agents was mediated partly through cell cycle arrest and induction of apoptosis, both in vitro and in vivo. We further demonstrate that benzimidazole treatment prolongs the survival of mice bearing prostate cancer lung metastases and inhibit the growth of prostate cancer cells growing in the bone microenvironment. More strikingly, these anti-tumor effects remain active against prostate cancer cells that are resistant to paclitaxel, the standard chemotherapy for men with advanced prostate cancer, both in vitro as well as in vivo. Our study further supports the use of benzimidazoles as potential anti-cancer therapy for men with metastatic prostate cancer."
Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme (Sept., 2011) -- "Our findings indicate that mebendazole is a possible novel anti-brain tumor therapeutic that could be further tested in clinical trials."
The Antitumor Potentials of Benzimidazole Anthelmintics as Repurposing Drugs (Aug., 2020) -- "Benzimidazole anthelmintics have broad-spectrum action to remove parasites both in human and veterinary medicine. In addition to being antiparasitic agents, benzimidazole anthelmintics are known to exert anticancer activities, such as the disruption of microtubule polymerization, the induction of apoptosis, cell cycle (G2/M) arrest, anti-angiogenesis, and blockage of glucose transport. These antitumorigenic effects even extend to cancer cells resistant to approved therapies. . ."
The Benzimidazole-Based Anthelmintic Parbendazole: A Repurposed Drug Candidate That Synergizes with Gemcitabine in Pancreatic Cancer -- This article states that Parbendazole and Oxibendazole are more effective compared to Fenbendazole and Mebendazole in Pancreatic Cancer. However, it should be noted that in Joe Tippins' celebrated case, the mets to his pancreas were cleared out, as well.